Apple Roundup: Wearables Lead, EU Tax, Healthcare, Trump Tariffs
Zacks Investment Research | Mar 05, 2018 05:16AM ET
Apple (NASDAQ:AAPL) topped the wearables market for the first time, and it seems to be a replay of what it did in smartphones.
Apple Leads in Wearable Devices
The device category that Fitbit (NYSE:FIT) pioneered is rapidly changing character as consumer tastes move from basic bands to smartwatches offering greater functionality and cellular connectivity. That’s the market that Apple has latched onto so well to become the leading player with fourth quarter unit shipments of 8 million, market share of 21% and representing growth of 57.5%, according to IDC.
Despite its purchase of smartwatch maker Pebble and the subsequent launch of its Ionic smartwatch, Fitbit has been pushed to second place with 5.4 million units, which is 14.2% of the market and represents a 17.3% decline from last year. Xiaomi, Garmin (NASDAQ:GRMN) and Huawei follow with 13%, 6.5% and 4.3% market share, respectively. Huawei saw the strongest growth of 93.2% in the last quarter.
Other News--
- EU Competition Commissioner Margrethe Vestager told CNBC that the European Commission will withdraw its complaint against Ireland for not recovering 13 billion euros ($16 billion) in unpaid taxes from Apple if it recovers the full amount. Considering the complex process, she has offered to overlook the considerable delay in recovery. Irish authorities have said that their calculations thus far are close to the commission's 13 billion euro figure.
- Apple could be taking baby steps in healthcare with its new subsidiary AC Wellness Network, LLC, first spotted by CNBC, which has the stated mission of delivering “the world’s best healthcare experiences for Apple employees.” On the face of it, Apple is adding to its corporate responsibilities by ensuring that its employees stay healthy. But it’s worth noting that the Cupertino-based company sells a smartwatch that’s expert at tracking healthcare metrics, as well as a very useful Health app. Last January, it introduced a new feature into the app that allows users to check their medical records on their iPhones. Tech peer Alphabet (NASDAQ:GOOGL) has made more public moves into healthcare with its startups. Recently, Amazon (NASDAQ:AMZN) has done likewise through its collaboration with leading banks. So it's not too much of a stretch to think that Apple would also be in the fray.
- President Trump has proposed a 25% tariff on imported raw steel and 10% tariff on imported raw aluminum that is broadly expected to increase the price of many products that use these materials for packaging or otherwise. While a number of Apple products use Aluminum, it won’t be affected. As Gene Munster of Loup Ventures says, "The only thing they make in the U.S. right now is the high-end Mac Pro," which probably accounts for about 1% of sales. So even if the cost of producing that 1% goes up 10%, there will hardly be any impact on Apple’s profits.
Get The News You Want
Apple shares carry a Zacks Rank #3 (Hold). But you can see .
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.